$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Exploring the In Vivo Anti-Inflammatory Actions of Simvastatin-Loaded Porous Microspheres on Inflamed Tenocytes in a Collagenase-Induced Animal Model of Achilles Tendinitis 원문보기

International journal of molecular sciences, v.19 no.3, 2018년, pp.820 -   

Jeong, Chandong (Department of Orthopedic Surgery and Rare Diseases Institute, Korea University College of Medicine, Guro Hospital, Guro-dong, Guro-gu, Seoul 08308, Korea) ,  Kim, Sung Eun (cdjeong85@gmail.com (C.J.)) ,  Shim, Kyu-Sik (sekim10@korea.ac.kr (S.E.K.)) ,  Kim, Hak-Jun (dakjul@korea.ac.kr (H.-J.K.)) ,  Song, Mi Hyun (wwiiw@naver.com (M.H.S.)) ,  Park, Kyeongsoon (Department of Orthopedic Surgery and Rare Diseases Institute, Korea University College of Medicine, Guro Hospital, Guro-dong, Guro-gu, Seoul 08308, Korea) ,  Song, Hae-Ryong (cdjeong85@gmail.com (C.J.))

Abstract AI-Helper 아이콘AI-Helper

Tendon rupture induces an inflammatory response characterized by release of pro-inflammatory cytokines and impaired tendon performance. This study sought to investigate the therapeutic effects of simvastatin-loaded porous microspheres (SIM/PMSs) on inflamed tenocytes in vitro and collagenase-induced...

주제어

참고문헌 (45)

  1. 1. Lopez R.G. Jung H.G. Achilles tendinosis: Treatment options Clin. Orthop. Surg. 2015 7 1 7 10.4055/cios.2015.7.1.1 25729512 

  2. 2. Maffulli N. Khan K.M. Puddu G. Overuse tendon conditions: Time to change a confusing terminology Arthroscopy 1998 14 840 843 10.1016/S0749-8063(98)70021-0 9848596 

  3. 3. Sharma P. Maffulli N. Tendon injury and tendinopathy: Healing and repair J. Bone Jt. Surg. Am. 2005 87 187 202 

  4. 4. Nagase H. Visse R. Murphy G. Structure and function of matrix metalloproteinases and timps Cardiovasc. Res. 2006 69 562 573 10.1016/j.cardiores.2005.12.002 16405877 

  5. 5. Langberg H. Boushel R. Skovgaard D. Risum N. Kjaer M. Cyclo-oxygenase-2 mediated prostaglandin release regulates blood flow in connective tissue during mechanical loading in humans J. Physiol. 2003 551 683 689 10.1113/jphysiol.2003.046094 12813143 

  6. 6. Schulze-Tanzil G. Al-Sadi O. Wiegand E. Ertel W. Busch C. Kohl B. Pufe T. The role of pro-inflammatory and immunoregulatory cytokines in tendon healing and rupture: New insights Scand. J. Med. Sci. Sports 2011 21 337 351 10.1111/j.1600-0838.2010.01265.x 21210861 

  7. 7. Moore R.A. Tramer M.R. Carroll D. Wiffen P.J. McQuay H.J. Quantitative systematic review of topically applied non-steroidal anti-inflammatory drugs BMJ 1998 316 333 338 10.1136/bmj.316.7128.333 9487165 

  8. 8. Fredberg U. Stengaard-Pedersen K. Chronic tendinopathy tissue pathology, pain mechanisms, and etiology with a special focus on inflammation Scand. J. Med. Sci. Sports 2008 18 3 15 10.1111/j.1600-0838.2007.00746.x 18294189 

  9. 9. Smidt N. van der Windt D.A. Assendelft W.J. Deville W.L. Korthals-de Bos I.B. Bouter L.M. Corticosteroid injections, physiotherapy, or a wait-and-see policy for lateral epicondylitis: A randomised controlled trial Lancet 2002 359 657 662 10.1016/S0140-6736(02)07811-X 11879861 

  10. 10. Tsai W.C. Yu T.Y. Lin L.P. Cheng M.L. Chen C.L. Pang J.H. Prevention of simvastatin-induced inhibition of tendon cell proliferation and cell cycle progression by geranylgeranyl pyrophosphate Toxicol. Sci. 2016 149 326 334 10.1093/toxsci/kfv239 26577051 

  11. 11. McFarland A.J. Davey A.K. Anoopkumar-Dukie S. Statins reduce lipopolysaccharide-induced cytokine and inflammatory mediator release in an in vitro model of microglial-like cells Med. Inflamm. 2017 2017 2582745 10.1155/2017/2582745 28546657 

  12. 12. Rosenson R.S. Tangney C.C. Casey L.C. Inhibition of proinflammatory cytokine production by pravastatin Lancet 1999 353 983 984 10.1016/S0140-6736(98)05917-0 

  13. 13. Loppnow H. Zhang L. Buerke M. Lautenschlager M. Chen L. Frister A. Schlitt A. Luther T. Song N. Hofmann B. Statins potently reduce the cytokine-mediated IL-6 release in SMC/MNC cocultures J. Cell. Mol. Med. 2011 15 994 1004 10.1111/j.1582-4934.2010.01036.x 20158569 

  14. 14. Marschner I.C. Colquhoun D. Simes R.J. Glasziou P. Harris P. Singh B.B. Friedlander D. White H. Thompson P. Tonkin A. Long-term risk stratification for survivors of acute coronary syndromes. Results from the long-term intervention with pravastatin in ischemic disease (lipid) study. Lipid study investigators J. Am. Coll. Cardiol. 2001 38 56 63 10.1016/S0735-1097(01)01360-2 11451296 

  15. 15. Hayem G. Statins and muscles: What price glory? Jt. Bone Spine 2002 69 249 251 10.1016/S1297-319X(02)00389-5 

  16. 16. Kashani A. Sallam T. Bheemreddy S. Mann D.L. Wang Y. Foody J.M. Review of side-effect profile of combination ezetimibe and statin therapy in randomized clinical trials Am. J. Cardiol. 2008 101 1606 1613 10.1016/j.amjcard.2008.01.041 18489938 

  17. 17. Eliasson P. Svensson R.B. Giannopoulos A. Eismark C. Kjaer M. Schjerling P. Heinemeier K.M. Simvastatin and atorvastatin reduce the mechanical properties of tendon constructs in vitro and introduce catabolic changes in the gene expression pattern PLoS ONE 2017 12 e0172797 10.1371/journal.pone.0172797 28264197 

  18. 18. Kim S.E. Yun Y.P. Shim K.S. Park K. Choi S.W. Shin D.H. Suh D.H. Fabrication of a BMP-2-immobilized porous microsphere modified by heparin for bone tissue engineering Coll. Surf. B Biointerfaces 2015 134 453 460 10.1016/j.colsurfb.2015.05.003 26231738 

  19. 19. Park J.W. Yun Y.P. Park K. Lee J.Y. Kim H.J. Kim S.E. Song H.R. Ibuprofen-loaded porous microspheres suppressed the progression of monosodium iodoacetate-induced osteoarthritis in a rat model Coll. Surf. B Biointerfaces 2016 147 265 273 10.1016/j.colsurfb.2016.07.050 27521747 

  20. 20. Lee J.Y. Kim S.E. Yun Y.P. Choi S.W. Jeon D.I. Kim H.J. Park K. Song H.R. Osteogenesis and new bone formation of alendronate-immobilized porous plga microspheres in a rat calvarial defect model J. Ind. Eng. Chem. 2017 52 277 286 10.1016/j.jiec.2017.03.057 

  21. 21. Kim S.E. Yun Y.P. Shim K.S. Jeon D.I. Park K. Kim H.J. In vitro and in vivo anti-inflammatory and tendon-healing effects in achilles tendinopathy of long-term curcumin delivery using porous microspheres J. Ind. Eng. Chem. 2018 58 123 130 10.1016/j.jiec.2017.09.016 

  22. 22. Hollinger J.O. Battistone G.C. Biodegradable bone repair materials. Synthetic polymers and ceramics Clin. Orthop. Relat. Res. 1986 290 305 

  23. 23. Maffulli N. Wong J. Almekinders L.C. Types and epidemiology of tendinopathy Clin. Sports Med. 2003 22 675 692 10.1016/S0278-5919(03)00004-8 14560540 

  24. 24. Weber C. Erl W. Weber K.S. Weber P.C. HMG-CoA reductase inhibitors decrease CD11b expression and CD11b-dependent adhesion of monocytes to endothelium and reduce increased adhesiveness of monocytes isolated from patients with hypercholesterolemia J. Am. Coll. Cardiol. 1997 30 1212 1217 10.1016/S0735-1097(97)00324-0 9350917 

  25. 25. Buchwald H. Campos C.T. Boen J.R. Nguyen P.A. Williams S.E. Disease-free intervals after partial ileal bypass in patients with coronary heart disease and hypercholesterolemia: Report from the program on the surgical control of the hyperlipidemias (posch) J. Am. Coll. Cardiol. 1995 26 351 357 10.1016/0735-1097(95)80006-3 7608434 

  26. 26. Contractor T. Beri A. Gardiner J.C. Tang X. Dwamena F.C. Is statin use associated with tendon rupture? A population-based retrospective cohort analysis Am. J. Ther. 2015 22 377 381 10.1097/MJT.0000000000000039 24451300 

  27. 27. Beri A. Dwamena F.C. Dwamena B.A. Association between statin therapy and tendon rupture: A case-control study J. Cardiovasc. Pharmacol. 2009 53 401 404 10.1097/FJC.0b013e3181a0ce8b 19454900 

  28. 28. Lin T.T. Lin C.H. Chang C.L. Chi C.H. Chang S.T. Sheu W.H. The effect of diabetes, hyperlipidemia, and statins on the development of rotator cuff disease: A nationwide, 11-year, longitudinal, population-based follow-up study Am. J. Sports Med. 2015 43 2126 2132 10.1177/0363546515588173 26085191 

  29. 29. Dolkart O. Liron T. Chechik O. Somjen D. Brosh T. Maman E. Gabet Y. Statins enhance rotator cuff healing by stimulating the COX2/PGE2/EP4 pathway: An in vivo and in vitro study Am. J. Sports Med. 2014 42 2869 2876 10.1177/0363546514545856 25184246 

  30. 30. Hoffman K.B. Kraus C. Dimbil M. Golomb B.A. A survey of the FDA’s AERS database regarding muscle and tendon adverse events linked to the statin drug class PLoS ONE 2012 7 e42866 10.1371/journal.pone.0042866 22936996 

  31. 31. De Oliveira L.P. Vieira C.P. Guerra F.D. Almeida M.S. Pimentel E.R. Structural and biomechanical changes in the achilles tendon after chronic treatment with statins Food Chem. Toxicol. 2015 77 50 57 10.1016/j.fct.2014.12.014 25544391 

  32. 32. Marie I. Delafenetre H. Massy N. Thuillez C. Noblet C. Network of the French Pharmacovigilance Centers. Tendinous disorders attributed to statins: A study on ninety-six spontaneous reports in the period 1990–2005 and review of the literature Arthritis Rheum. 2008 59 367 372 10.1002/art.23309 18311771 

  33. 33. Tsuzaki M. Guyton G. Garrett W. Archambault J.M. Herzog W. Almekinders L. Bynum D. Yang X. Banes A.J. IL-1 beta induces COX2, MMP-1, -3 and -13, ADAMTS-4, IL-1 beta and IL-6 in human tendon cells J. Orthop. Res. 2003 21 256 264 10.1016/S0736-0266(02)00141-9 12568957 

  34. 34. John T. Lodka D. Kohl B. Ertel W. Jammrath J. Conrad C. Stoll C. Busch C. Schulze-Tanzil G. Effect of pro-inflammatory and immunoregulatory cytokines on human tenocytes J. Orthop. Res. 2010 28 1071 1077 10.1002/jor.21079 20127972 

  35. 35. Niwa S. Totsuka T. Hayashi S. Inhibitory effect of fluvastatin, an hmg-coa reductase inhibitor, on the expression of adhesion molecules on human monocyte cell line Int. J. Immunopharmacol. 1996 18 669 675 10.1016/S0192-0561(96)00068-9 9089010 

  36. 36. Kothe H. Dalhoff K. Rupp J. Muller A. Kreuzer J. Maass M. Katus H.A. Hydroxymethylglutaryl coenzyme a reductase inhibitors modify the inflammatory response of human macrophages and endothelial cells infected with chlamydia pneumoniae Circulation 2000 101 1760 1763 10.1161/01.CIR.101.15.1760 10769273 

  37. 37. Luan Z. Chase A.J. Newby A.C. Statins inhibit secretion of metalloproteinases-1, -2, -3, and -9 from vascular smooth muscle cells and macrophages Arterioscler. Thromb. Vasc. Biol. 2003 23 769 775 10.1161/01.ATV.0000068646.76823.AE 12663370 

  38. 38. Hast M.W. Zuskov A. Soslowsky L.J. The role of animal models in tendon research Bone Jt. Res. 2014 3 193 202 10.1302/2046-3758.36.2000281 24958818 

  39. 39. Patterson-Kane J.C. Firth E.C. Parry D.A. Wilson A.M. Goodship A.E. Effects of training on collagen fibril populations in the suspensory ligament and deep digital flexor tendon of young thoroughbreds Am. J. Vet. Res. 1998 59 64 68 9442247 

  40. 40. Rosso F. Bonasia D.E. Marmotti A. Cottino U. Rossi R. Mechanical stimulation (pulsed electromagnetic fields “pemf” and extracorporeal shock wave therapy “eswt”) and tendon regeneration: A possible alternative Front. Aging Neurosci. 2015 7 211 10.3389/fnagi.2015.00211 26617513 

  41. 41. Aspenberg P. Stimulation of tendon repair: Mechanical loading, gdfs and platelets. A mini-review Int. Orthop. 2007 31 783 789 10.1007/s00264-007-0398-6 17583812 

  42. 42. Ricchetti E.T. Reddy S.C. Ansorge H.L. Zgonis M.H. Van Kleunen J.P. Liechty K.W. Soslowsky L.J. Beredjiklian P.K. Effect of interleukin-10 overexpression on the properties of healing tendon in a murine patellar tendon model J. Hand Surg. Am. 2008 33 1843 1852 10.1016/j.jhsa.2008.07.020 19084188 

  43. 43. Lichtnekert J. Kawakami T. Parks W.C. Duffield J.S. Changes in macrophage phenotype as the immune response evolves Curr. Opin. Pharmacol. 2013 13 555 564 10.1016/j.coph.2013.05.013 23747023 

  44. 44. Jeong Y.J. Kim I. Cho J.H. Park D.W. Kwon J.E. Jung M.W. Meng X. Jo S.M. Song H.S. Cho Y.M. Anti-osteoarthritic effects of the litsea japonica fruit in a rat model of osteoarthritis induced by monosodium iodoacetate PLoS ONE 2015 10 e0134856 10.1371/journal.pone.0134856 26244981 

  45. 45. Xu Y. Liu Q. Liu Z.L. Lim L. Chen W.H. Lin N. Treatment with simiaofang, an anti-arthritis chinese herbal formula, inhibits cartilage matrix degradation in osteoarthritis rat model Rejuvenation Res. 2013 16 364 376 10.1089/rej.2013.1439 23799821 

LOADING...

관련 콘텐츠

오픈액세스(OA) 유형

GOLD

오픈액세스 학술지에 출판된 논문

저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로